Overall rank by patents
#47,074
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F16B (Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing).
The verdict
According to USPTO PatentsView, Glabete ranks #47,074 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R47074 · Foreign Corporation #47,074 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Gigajot Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Glabete · this assignee
25 score
3D Lighting… · lowest
7 score
What this shows Glabete's Innovation Score is 25.2/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Glabete GmbH is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under F16B (Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2016. By volume, Glabete sits between Gigajot Technologies, Inc. and Glebar Acquisition, LLC.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Gigajot Technologies, Inc.
5 patents
Gilgamesh Pharmaceuticals, Inc.
5 patents
Gill Industries, Inc.
5 patents
GitLab Inc.
5 patents
Glass Dynamics, Inc.
5 patents
Glassbeam, Inc.
5 patents
Glatfelter Gernsbach GmbH
5 patents
Glebar Acquisition, LLC
5 patents
Glabete GmbH
5 patents
What this shows Glabete holds 5 patents at rank #47,183, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,183 in granted patent volume.
Other assignees with the most granted patents in Glabete's primary technology class.
Glabete's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 17th percentile higher than 17% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2017 | 1 | 20.0% |
| 2018 | 2 | 40.0% |
| 2020 | 1 | 20.0% |
Top 11 of 11 technology areas
Overall rank by patents
#47,074
of 49,997 tracked assignees
25.2 out of 100
What to do with this data
Glabete GmbH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.